ELAB (PMGC Holdings) Return-on-Tangible-Asset: -135.28% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ELAB PMGC Holdings Inc ELAB
8 GF Score
Price $1.07
! 1 Warning Sign
View Full Analysis

What is PMGC Holdings Return-on-Tangible-Asset?

PMGC Holdings ELAB -0.47% 8 Return-on-Tangible-Asset is -135.28% as of Mar. 2026. GuruFocus rates ELAB with a GF Score™ of 8/100. The stock has 1 warning sign investors should review. Among 1,416 Biotechnology companies, PMGC Holdings ranks worse than 79.1% on this metric.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. PMGC Holdings's annualized Net Income for the quarter that ended in Mar. 2026 was $-19.87 Mil. PMGC Holdings's average total tangible assets for the quarter that ended in Mar. 2026 was $14.69 Mil. Therefore, PMGC Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -135.28%.

The historical rank and industry rank for PMGC Holdings's Return-on-Tangible-Asset or its related term are showing as below:

ELAB' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -140.73   Med: -117.87   Max: -101.11
Current: -101.11

During the past 5 years, PMGC Holdings's highest Return-on-Tangible-Asset was -101.11%. The lowest was -140.73%. And the median was -117.87%.

ELAB's Return-on-Tangible-Asset is ranked worse than
79.1% of 1416 companies
in the Biotechnology industry
Industry Median: -35.915 vs ELAB: -101.11

PMGC Holdings  (NAS:ELAB) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


PMGC Holdings Return-on-Tangible-Asset Related Terms


PMGC Holdings Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for PMGC Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PMGC Holdings Return-on-Tangible-Asset Chart

PMGC Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Asset
-117.87 -140.73 -121.49 -109.76 -102.02

PMGC Holdings Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -98.90 -31.85 -110.78 -116.82 -135.28

ELAB vs MBIO, PCSA, DRMA: Return-on-Tangible-Asset Comparison

For the Biotechnology subindustry, PMGC Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PMGC Holdings Return-on-Tangible-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PMGC Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where PMGC Holdings's Return-on-Tangible-Asset falls into.


ELAB
8GF Score
PMGC Holdings Inc ELAB
Return-on-Tangible-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PMGC Holdings Return-on-Tangible-Asset Calculation

PMGC Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-7.748/( (6.191+8.998)/ 2 )
=-7.748/7.5945
=-102.02 %

PMGC Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-19.868/( (8.998+20.375)/ 2 )
=-19.868/14.6865
=-135.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data.

What does a Return-on-Tangible-Asset of -135.28% mean?
PMGC Holdings (ELAB) has a Return-on-Tangible-Asset of -135.28% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on PMGC Holdings and its competitors. According to the industry distribution chart, PMGC Holdings ranks #1120 out of 1416 companies in the Biotechnology industry, placing it in the top 79.1%.
Is PMGC Holdings' Return-on-Tangible-Asset too high?
PMGC Holdings' current Return-on-Tangible-Asset is -135.28%. Based on the distribution chart, PMGC Holdings ranks #1120 out of 1416 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PMGC Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does PMGC Holdings' Return-on-Tangible-Asset compare to MBIO and PCSA?
According to the Biotechnology industry distribution chart, PMGC Holdings ranks #1120 out of 1416 companies for Return-on-Tangible-Asset. This places PMGC Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Biotechnology company?
A good Return-on-Tangible-Asset depends on the Biotechnology industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on PMGC Holdings and its competitors. PMGC Holdings's current Return-on-Tangible-Asset is -135.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMGC Holdings stock overvalued right now?
PMGC Holdings (ELAB) has a current Return-on-Tangible-Asset of -135.28%. The current Return-on-Tangible-Asset is -135.28%. PMGC Holdings' overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For PMGC Holdings (ELAB), the current Return-on-Tangible-Asset is -135.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PMGC Holdings Business Description

Address C/O 120 Newport Center Drive, Suite 250, Newport Beach, CA, USA, 92660
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
8GF Score

Get the complete analysis for ELAB

Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.07
Price